ArticleCancer immunology, immunotherapy : CII2021

APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application.

Erin L Filbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.